Total Funding
55
4
Total FundingSeries A raised
Growth Score 55 in past quarter
-8 pts
Heat Score 4 in past quarter
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
367021
Accumen partners with hospitals and health systems to deliver Laboratory Excellence and Comprehensive Patient Blood Management.
- Michael Cline: Founder & DirectorPast Role: McKinsey & Company, Associates
Jeff Downs: Vice President Sales and GM, Consulting Services
About the Company
Accumen partners with hospitals and health systems to deliver Laboratory Excellence and Comprehensive Patient Blood Management. By partnering with clients to operate their labs, rather than providing independent or outsourced laboratory services, Accumen provides a unique value proposition to health systems. Accumen's innovative approach helps
health systems and associated physician groups retain control of the continuum of care, and achieve measurable improvements in lab excellence and efficiency through a comprehensive approach to people, process, and technology that both optimizes and modernizes hospital lab operations.


